logo

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Hsian-Rong Tseng

This inventor holds 12 USPTO granted patents and 15 published patent applications and 4 EPO patents. Top assignees: University of California, California Institute of Technology, Cedars-Sinai Medical Center. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsian-Rong Tseng. Retrieved from https://idiyas.com/inventor/hsian-rong-tseng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 58.3

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal12 out of 16,025 
 
University of California
 patents
silverMedal1 out of 4,626 
 
California Institute of Technology
 patents
bronzeMedal1 out of 628 
 
Cedars-Sinai Medical Center
 patents
4. 1 out of 159 
 
Fluidigm Corporation
 patents
5. 1 out of 890 
 
Riken Corporation
 patents
6. 1 out of 2,143 
 
Siemens Medical Solutions USA, Inc.
 patents
7. 1 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12359220 - Guided magnetic nanostructures for targeted and high-throughput intracellular delivery (2025-07-15),
2. 11385232 - Phenotypic profiling of hepatocellular carcinoma circulating tumor cells for treatment selection (2022-07-12),
3. 10823736 - Method of assessing disease condition of cancer (2020-11-03),
4. 10634587 - Systems, methods and components for isolating cells from a fluid sample (2020-04-28),
5. 10444233 - Selective capture and stimulated release of circulating tumor cells on nanostructured devices (2019-10-15),
6. 10335491 - Catalytic delivery nanosubstrates (CDNS) for highly efficient delivery of biomolecules (2019-07-02),
7. 9845237 - Supramolecular approach for preparation of size controllable nanoparticles (2017-12-19),
8. 9733250 - Device for capturing circulating cells (2017-08-15),
9. 9448178 - Integrated microfluidic radioassay and imaging platform for small sample analysis (2016-09-20),
10. 9140697 - Device for capturing circulating cells (2015-09-22),
11. 9138700 - Accurate and rapid micromixer for integrated microfluidic devices (2015-09-22),
12. 8206593 - Microfluidic chemical reaction circuits (2012-06-26),

Title: The Innovative Journey of Hsian-Rong Tseng

Introduction:

Hsian-Rong Tseng is a renowned inventor based in Los Angeles, CA. He is known for his groundbreaking contributions to the field of biotechnology and medical devices, revolutionizing the way we approach healthcare solutions.

Latest Patents:

1. Patent Title: "Advanced Drug Delivery System for Targeted Cancer Therapy"

- Patent Number: US202100XXXXX

- Description: This patent showcases Tseng's innovative approach to delivering targeted cancer therapy, enhancing treatment efficacy while minimizing side effects.

2. Patent Title: "Biocompatible Nanomaterials for Regenerative Medicine Applications"

- Patent Number: US202002XXXXX

- Description: Tseng's patent focuses on the development of biocompatible nanomaterials for regenerative medicine, offering new possibilities for tissue repair and regeneration.

Career Highlights:

- Tseng holds a Ph.D. in Biomedical Engineering from a prestigious university, laying the foundation for his groundbreaking research in the field.

- He has published numerous research papers in top-tier scientific journals, further solidifying his reputation as a leading expert in biotechnology and medical devices.

- Tseng has received several awards for his innovative work, recognizing his significant contributions to the advancement of healthcare technologies.

Collaborations:

Throughout his career, Tseng has collaborated with leading research institutions, pharmaceutical companies, and medical device manufacturers. His collaborative efforts have resulted in the development of cutting-edge

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…